These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 23807646)

  • 21. Contribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosus.
    Mackern-Oberti JP; Llanos C; Riedel CA; Bueno SM; Kalergis AM
    Immunology; 2015 Dec; 146(4):497-507. PubMed ID: 26173489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PKK deficiency in B cells prevents lupus development in Sle lupus mice.
    Oleksyn D; Zhao J; Vosoughi A; Zhao JC; Misra R; Pentland AP; Ryan D; Anolik J; Ritchlin C; Looney J; Anandarajah AP; Schwartz G; Calvi LM; Georger M; Mohan C; Sanz I; Chen L
    Immunol Lett; 2017 May; 185():1-11. PubMed ID: 28274793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TJ-M2010-5, a novel MyD88 inhibitor, corrects R848-induced lupus-like immune disorders of B cells in vitro.
    Zou Z; Du D; Miao Y; Yang Y; Xie Y; Li Z; Zhou L; Zhang L; Zhou P; Jiang F
    Int Immunopharmacol; 2020 Aug; 85():106648. PubMed ID: 32504998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple Functions of B Cells in the Pathogenesis of Systemic Lupus Erythematosus.
    Ma K; Du W; Wang X; Yuan S; Cai X; Liu D; Li J; Lu L
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breakdown of Immune Tolerance in Systemic Lupus Erythematosus by Dendritic Cells.
    Liao X; Reihl AM; Luo XM
    J Immunol Res; 2016; 2016():6269157. PubMed ID: 27034965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleosomes contribute to increase mesangial cell chemokine expression during the development of lupus nephritis.
    Kanapathippillai P; Hedberg A; Fenton CG; Fenton KA
    Cytokine; 2013 May; 62(2):244-52. PubMed ID: 23561928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct transfer of p65 into T lymphocytes from systemic lupus erythematosus patients leads to increased levels of interleukin-2 promoter activity.
    Herndon TM; Juang YT; Solomou EE; Rothwell SW; Gourley MF; Tsokos GC
    Clin Immunol; 2002 May; 103(2):145-53. PubMed ID: 12027419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune cells and cytokines in systemic lupus erythematosus: an update.
    Kyttaris VC; Juang YT; Tsokos GC
    Curr Opin Rheumatol; 2005 Sep; 17(5):518-22. PubMed ID: 16093827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mouse models of systemic lupus erythematosus reveal a complex pathogenesis.
    Rottman JB; Willis CR
    Vet Pathol; 2010 Jul; 47(4):664-76. PubMed ID: 20448279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic potential of DCB-SLE1, an extract of a mixture of Chinese medicinal herbs, for severe lupus nephritis.
    Tsai PY; Ka SM; Chang JM; Chang WL; Huang YJ; Hung LM; Jheng HL; Wu RY; Chen A
    Am J Physiol Renal Physiol; 2011 Oct; 301(4):F751-64. PubMed ID: 21677146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of B Cell-Intrinsic TLR Signals in Systemic Lupus Erythematosus.
    Ma K; Li J; Fang Y; Lu L
    Int J Mol Sci; 2015 Jun; 16(6):13084-105. PubMed ID: 26068236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Physiopathology of systemic lupus erythematosus: a 2014 update].
    Mathian A; Arnaud L; Amoura Z
    Rev Med Interne; 2014 Aug; 35(8):503-11. PubMed ID: 24262408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pathogenesis of systemic lupus erythematosus (LES)].
    Conti G; Coppo R; Amore A
    G Ital Nefrol; 2012; 29 Suppl 54():S84-90. PubMed ID: 22388837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of HLA-DR genotype in systemic lupus erythematosus and lupus nephritis: a meta-analysis.
    Niu Z; Zhang P; Tong Y
    Int J Rheum Dis; 2015 Jan; 18(1):17-28. PubMed ID: 25546242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The expressions of Toll-like receptor 9 and T-bet in circulating B and T cells in newly diagnosed, untreated systemic lupus erythematosus and correlations with disease activity and laboratory data in a Chinese population.
    Wu O; Chen GP; Chen H; Li XP; Xu JH; Zhao SS; Sheng J; Feng JB; Cai J; Fang XH; Zhang WH; Li LH; Zhang N; Li J; Li JJ; Pan FM; Wang CZ; Ye DQ
    Immunobiology; 2009; 214(5):392-402. PubMed ID: 19362685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lupus nephritis: from pathogenesis to targets for biologic treatment.
    Liu Y; Anders HJ
    Nephron Clin Pract; 2014; 128(3-4):224-31. PubMed ID: 25401461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors.
    Christensen SR; Shlomchik MJ
    Semin Immunol; 2007 Feb; 19(1):11-23. PubMed ID: 17276080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Molecular targets and their regulation in systemic lupus erythematosus and lupus nephritis].
    Takasaki Y
    Nihon Jinzo Gakkai Shi; 2012; 54(5):598-602. PubMed ID: 22991839
    [No Abstract]   [Full Text] [Related]  

  • 39. OMIP-038: Innate immune assessment with a 14 color flow cytometry panel.
    Smolen KK; Cai B; Kollmann TR
    Cytometry A; 2017 Oct; 91(10):966-968. PubMed ID: 28419701
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of innate immune responses in autoimmune disease development.
    Waldner H
    Autoimmun Rev; 2009 Mar; 8(5):400-4. PubMed ID: 19162250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.